聚力赋能 共创未来,临港集团举行生物医药产业专场对接会
Tai Mei Ti A P P·2025-12-24 07:43

Core Insights - The conference focused on the biopharmaceutical industry, aiming to create a high-end ecological platform for industry and capital integration to support Shanghai's goal of becoming a global biopharmaceutical innovation hub [1] Group 1: Company Strategy and Development - Lingang Group has established 28 parks across 16 districts in Shanghai, housing over 24,000 enterprises, and is positioning itself as a leading service provider for innovative ecological integration in biopharmaceuticals [2] - The group emphasizes biopharmaceuticals as one of Shanghai's three strategic industries, with a focus on creating a "Life Blue Bay" in the Lingang New Area, fostering research and high-end manufacturing [2] - The company is transitioning from a "space provider" to an "ecosystem builder," leveraging a fund and base model to mobilize a fund scale of 170 billion yuan [2] Group 2: Industry Collaboration and Innovation - The "招投联动" (Investment and Recruitment Linkage) model is a key driver for empowering the biopharmaceutical ecosystem, integrating capital with industry innovation [4] - The establishment of the "Nucleic Acid Drug Clinical Transformation Concept Verification Center" aims to address bottlenecks in the development of nucleic acid drugs, providing comprehensive support from early research to clinical application [12] - The conference featured discussions on the internationalization of the biopharmaceutical industry, with insights from multinational companies and domestic innovators on building a comprehensive service system for global development [14] Group 3: Investment and Partnerships - Lingang Group's investment platform, including the Lingchuang Blue Bay Fund, has signed agreements with innovative companies like Tianchen Biotech and Orange Sail Medicine, focusing on dual-directional linkage between capital investment and industrial bases [8] - The partnership with Meifengli aims to integrate core advantages and resources in the medical device industry, enhancing the innovation service ecosystem in Shanghai [6] - The conference highlighted the importance of collaboration among industry experts to support investment decision-making and project incubation [10]

聚力赋能 共创未来,临港集团举行生物医药产业专场对接会 - Reportify